PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Sodium chloride - Corneal oedema

PAD Profile : Sodium chloride - Corneal oedema

Brand Names Include :
AabChlor, Natklor

Traffic Light Status

Status 1 of 3.

Status :
Green
Important
Formulations :
  • Eye drops
Important Information :
5% eye drops for corneal oedema. Primary Care to prescribe by brand - OptimiseRx will be used to identify the most cost effective brand at the point of prescribing
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 3.

Status :
Green
Important
Formulations :
  • Eye drops (preservative free)
Important Information :
5% preservative free eye drops for corneal oedema. Primary Care to prescribe by brand - OptimiseRx will be used to identify the most cost effective brand at the point of prescribing
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 3 of 3.

Status :
Green
Important
Formulations :
  • Eye ointment
Important Information :
Primary Care to prescribe generically as 5% eye ointment preservative free (Alissa Healthcare) - to ensure licensed, Tariff product is supplied.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

11. Eye
11.08.01. Tear deficiency, eye lubricant and astringent
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More